Novel phosphorylation-dependent ubiquitination of tristetraprolin by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1) and tumor necrosis factor receptor-associated factor 2 (TRAF2).
about
Polyubiquitinated tristetraprolin protects from TNF-induced, caspase-mediated apoptosisThe p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation.ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly.Dominant Suppression of Inflammation via Targeted Mutation of the mRNA Destabilizing Protein Tristetraprolin.Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathwayInteraction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer.TRAF molecules in cell signaling and in human diseasesTristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.Multiple functions of tristetraprolin/TIS11 RNA-binding proteins in the regulation of mRNA biogenesis and degradation.RNA binding proteins as regulators of immune cell biology.Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy.TRAF2 facilitates vaccinia virus replication by promoting rapid virus entry.Rapid proteasomal degradation of posttranscriptional regulators of the TIS11/tristetraprolin family is induced by an intrinsically unstructured region independently of ubiquitination.RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins.Systematic Analysis of Quantitative Logic Model Ensembles Predicts Drug Combination Effects on Cell Signaling NetworksThe role of RNA-binding protein tristetraprolin in cancer and immunity.
P2860
Q34139073-C60ADBA5-BBBC-463D-A150-DE0FCBC01101Q34426626-9BDA1694-5530-4F28-8DC4-2CA360E62733Q35621928-FE9785EB-18FE-4269-A77C-47159A1A8AA8Q35757055-EF5D8E0B-4259-4F53-B686-8C9E18EF8C80Q36464388-440DD78B-2B1D-4071-9255-E8784E910C61Q36561559-418A148E-8EFA-4A3C-8A71-E487B27CBFBFQ36633446-7631B6DB-4C7D-4C46-8DFD-A814BE7C3326Q36972287-2D43B6B0-BB26-4BB7-A1D3-3B5C5871B450Q37119721-81F6A2ED-781E-453E-B769-851BCA655829Q38042546-45F11B9D-C344-4519-8F2A-DED589302BB8Q38552147-18469258-C8CB-4DAA-AF93-916E58B59ACBQ38698632-6E7201AB-347B-4E90-BAAE-2A727B60247DQ38854837-C323665F-3270-448C-8B3A-4E77BC5339D3Q38954061-B8A905BB-3E41-4EC4-94A4-03E128F0208EQ39042850-79654F4C-D6FF-4056-BE82-CBD189DE7E89Q41582124-EE297559-305B-494F-899A-6697650015F8Q47417882-E287D8D9-A92C-48EA-A50C-57B7C481309F
P2860
Novel phosphorylation-dependent ubiquitination of tristetraprolin by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1) and tumor necrosis factor receptor-associated factor 2 (TRAF2).
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel phosphorylation-dependen ...... r-associated factor 2 (TRAF2).
@ast
Novel phosphorylation-dependen ...... r-associated factor 2 (TRAF2).
@en
type
label
Novel phosphorylation-dependen ...... r-associated factor 2 (TRAF2).
@ast
Novel phosphorylation-dependen ...... r-associated factor 2 (TRAF2).
@en
prefLabel
Novel phosphorylation-dependen ...... r-associated factor 2 (TRAF2).
@ast
Novel phosphorylation-dependen ...... r-associated factor 2 (TRAF2).
@en
P2093
P2860
P356
P1476
Novel phosphorylation-dependen ...... r-associated factor 2 (TRAF2).
@en
P2093
Christof E Lemberger
Dominik Stichlberger
Rainer de Martin
Yvonne M Schichl
P2860
P304
38466-38477
P356
10.1074/JBC.M111.254888
P407
P50
P577
2011-09-15T00:00:00Z